DISCuSs

  • Research type

    Research Study

  • Full title

    The development and pilot testing of a decision aid to better support patients with ulcerative colitis choose between ongoing medical treatment and surgical treatment options

  • IRAS ID

    257044

  • Contact name

    Alan Lobo

  • Contact email

    Alan.Lobo@sth.nhs.uk

  • Sponsor organisation

    Sheffield Teaching Hospitals NHS FT

  • Duration of Study in the UK

    2 years, 11 months, 31 days

  • Research summary

    Ulcerative colitis (UC) is a chronic condition with debilitating symptoms that can impair quality of life. UC can be managed both medically and surgically. Medical management aims to induce and maintain remission by controlling inflammation and reducing symptoms. Approximately 20-30% of patients with UC will undergo surgery. A small minority of patients will require emergency surgery; however, the vast majority of patients undergoing surgery will do so electively, instead of continuing with medical therapy. This study aims to develop and pilot a new Patient Decision Aid (PtDA) to better support patients with UC considering surgery. Both continuing medical and surgical treatments are associated with risks, and evidence suggests that patients find the decision-making process complex and difficult.
    National guidelines for UC emphasise the importance of providing information to support treatment decision-making, but the resources available are few and lack quality. This research aims to address this unmet need by developing a PtDA and gaining feedback on it from patients and clinicians prior to its pilot in two clinical centres. This PtDA will be developed with the study team, gastroenterologists, colorectal surgeons, nurse specialists and patients during stage 1. In stage 2, we will carry out focus groups and distribute questionnaires to patients and clinicians to refine the content and format of the information. In stage 3, we will introduce the PtDA into Sheffield and Hull and East Yorkshire Teaching Hospitals. We will measure the impact of the PtDA upon patient levels of anxiety, decision making change, decisional regret and quality of life.
    It is anticipated the resource will improve the quality of life of patients living with UC by helping them to make the right treatment decisions whilst providing a freely available tool for NHS clinical teams.

  • REC name

    North East - Tyne & Wear South Research Ethics Committee

  • REC reference

    19/NE/0073

  • Date of REC Opinion

    15 Mar 2019

  • REC opinion

    Favourable Opinion